CN116898780A - Anoectochilus roxburghii extract and preparation process and application thereof - Google Patents
Anoectochilus roxburghii extract and preparation process and application thereof Download PDFInfo
- Publication number
- CN116898780A CN116898780A CN202311122467.9A CN202311122467A CN116898780A CN 116898780 A CN116898780 A CN 116898780A CN 202311122467 A CN202311122467 A CN 202311122467A CN 116898780 A CN116898780 A CN 116898780A
- Authority
- CN
- China
- Prior art keywords
- extract
- anomatis
- anoectochilus
- anoectochilus roxburghii
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 101
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 238000000605 extraction Methods 0.000 title claims description 24
- 241000934230 Anoectochilus roxburghii Species 0.000 title claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000000843 powder Substances 0.000 claims abstract description 26
- 238000002137 ultrasound extraction Methods 0.000 claims abstract description 22
- 239000002904 solvent Substances 0.000 claims abstract description 18
- 239000000287 crude extract Substances 0.000 claims abstract description 15
- 239000003381 stabilizer Substances 0.000 claims abstract description 14
- 239000006184 cosolvent Substances 0.000 claims abstract description 12
- 239000000706 filtrate Substances 0.000 claims abstract description 12
- 239000003755 preservative agent Substances 0.000 claims abstract description 12
- 239000000047 product Substances 0.000 claims abstract description 12
- 230000002335 preservative effect Effects 0.000 claims abstract description 10
- 230000002829 reductive effect Effects 0.000 claims abstract description 8
- 238000000926 separation method Methods 0.000 claims abstract description 5
- 239000012528 membrane Substances 0.000 claims abstract description 4
- 238000010298 pulverizing process Methods 0.000 claims abstract 2
- 238000007873 sieving Methods 0.000 claims abstract 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 26
- 238000001179 sorption measurement Methods 0.000 claims description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 238000004042 decolorization Methods 0.000 claims description 16
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 14
- 239000011347 resin Substances 0.000 claims description 13
- 229920005989 resin Polymers 0.000 claims description 13
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 10
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 8
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 7
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 206010061218 Inflammation Diseases 0.000 claims description 5
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 5
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 5
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 5
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 4
- 235000010241 potassium sorbate Nutrition 0.000 claims description 4
- 239000004302 potassium sorbate Substances 0.000 claims description 4
- 229940069338 potassium sorbate Drugs 0.000 claims description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- 239000004283 Sodium sorbate Substances 0.000 claims description 3
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 3
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 claims description 3
- 235000019250 sodium sorbate Nutrition 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 241000719836 Anoectochilus formosanus Species 0.000 claims 2
- 229940035437 1,3-propanediol Drugs 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
- 241000719837 Anoectochilus Species 0.000 abstract description 39
- 239000007788 liquid Substances 0.000 abstract description 24
- 241000196324 Embryophyta Species 0.000 abstract description 12
- 239000012141 concentrate Substances 0.000 abstract description 9
- 230000001153 anti-wrinkle effect Effects 0.000 abstract description 6
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 18
- 239000002158 endotoxin Substances 0.000 description 14
- 229920006008 lipopolysaccharide Polymers 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 238000012360 testing method Methods 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 150000004676 glycans Chemical class 0.000 description 8
- 230000005012 migration Effects 0.000 description 8
- 238000013508 migration Methods 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000013112 stability test Methods 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 4
- 102000012422 Collagen Type I Human genes 0.000 description 4
- 108010022452 Collagen Type I Proteins 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 4
- 229960003957 dexamethasone Drugs 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 210000001626 skin fibroblast Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940096422 collagen type i Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0261—Solvent extraction of solids comprising vibrating mechanisms, e.g. mechanical, acoustical
- B01D11/0265—Applying ultrasound
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/028—Flow sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Acoustics & Sound (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Mechanical Engineering (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本申请提出一种金线莲提取物及其制备工艺、应用。金线莲提取物制备工艺,包括:将干燥的金线莲全株用粉碎机粉碎后过筛,得到干粉;将干粉加入到乙醇溶剂中,进行常温超声提取,得到金线莲粗提液;将金线莲粗提液过滤以除去渣滓,得到滤液;将所得滤液进行膜分离和/或减压浓缩除去乙醇,定容得到浓缩液;在所得浓缩液中加入助溶剂和稳定剂,之后进行脱色,得到金线莲脱色液;将金线莲脱色液过滤、除菌;将除菌后的溶液添加防腐剂,即得到金线莲提取物。金线莲提取物,由金线莲提取物制备工艺制备而成。金线莲提取物的应用,该应用为金线莲提取物在舒缓抗炎、或抗皱、或修护方面的护肤产品中的应用。
This application proposes a Anoectochilus extract and its preparation process and application. The preparation process of the Anomatis extract includes: pulverizing the dried whole Alematophora plant with a grinder and sieving to obtain dry powder; adding the dry powder to an ethanol solvent and performing ultrasonic extraction at room temperature to obtain a crude extract of Anomatis; Filter the crude extract of Anomatis to remove the residue and obtain a filtrate; conduct membrane separation and/or concentrate the obtained filtrate under reduced pressure to remove ethanol, and dilute to volume to obtain a concentrated liquid; add cosolvents and stabilizers to the obtained concentrated liquid, and then proceed Decolorize to obtain a Anomatis decolorizing solution; filter and sterilize the Anoectochus depigmenting solution; add a preservative to the sterilized solution to obtain a Anomatis extract. Anomatis extract is prepared by a Anoectochilus extract preparation process. The application of anomatis extract is the application of anomatis extract in skin care products that are soothing, anti-inflammatory, anti-wrinkle, or repairing.
Description
技术领域Technical field
本申请涉及一种皮肤护理技术领域,尤其涉及一种金线莲提取物及其制备工艺、应用。The present application relates to the technical field of skin care, and in particular to a Anoectochilus extract and its preparation process and application.
背景技术Background technique
金线莲(Anoectochilus roxburghii(Wall.)Lindl.),又名金线兰、金丝草、鸟人参、金线虎头蕉、金线入骨消等,为兰科开唇兰属多年生珍稀中草药,主要分布于我国福建、广东、浙江等南部省份,福建为金线莲的道地产区。金线莲全草可入药,《福建省中药材标准》(2006版)记载金线莲:“本品系闽台等省的民间珍稀草药,其性味功能性平、甘;清热凉血、祛风利湿;用于肾炎,支气管炎,膀胱炎,糖尿病,风湿性关节炎,小儿急惊风,毒蛇咬伤等症。金线莲富含黄酮、多糖及糖苷类、氨基酸、三萜类、酯类、甾醇及微量元素等物质,具有丰富的生物活性,能够有效抗炎、清除自由基、抗衰老等。目前金线莲产品的开发主要集中在鲜品、干茶、保健茶等产品上,结构单一,创新能力较弱,而在皮肤护理方面的应用和研究鲜少,尚不满足市场需求。Anoectochilus roxburghii (Wall.) Lindl., also known as Anoectochilus roxburghii (Wall.) Lindl., also known as Anoectochilus roxburghii (Wall.) Lindl., Anoectochilus roxburghii (Wall.) Lindl., also known as Anoectochilus roxburghii (Wall.) Lindl., Anoectochilus roxburghii (Wall.) Lindl. It is mainly distributed in southern provinces such as Fujian, Guangdong, and Zhejiang in my country. Fujian is the authentic production area of Anomatis. The whole plant of Anomatis can be used as medicine. "Fujian Provincial Traditional Chinese Medicinal Materials Standards" (2006 Edition) records Anoectochilus: "This strain is a rare folk herbal medicine in Fujian and Taiwan and other provinces. Its nature, flavor and functionality are flat and sweet; it clears away heat, cools blood, Dispelling wind and dampness; used for nephritis, bronchitis, cystitis, diabetes, rheumatoid arthritis, convulsions in children, snake bites and other diseases. Anoectochilus is rich in flavonoids, polysaccharides and glycosides, amino acids, triterpenes , esters, sterols and trace elements and other substances, which have rich biological activities and can effectively resist inflammation, scavenge free radicals, anti-aging, etc. At present, the development of Anomatis products is mainly focused on fresh products, dry tea, health tea and other products On the other hand, the structure is single, the innovation ability is weak, and there are few applications and researches in skin care, which still does not meet the market demand.
目前公开的金线莲的制备工艺较为复杂,并不适用于规模化生产。另外有的制备工艺得到的有效成分含量或者生物活性较低、活性成分不稳定性等,会在一定程度上造成金线莲资源的浪费。金线莲素有“药王”、“金草”的美称,是我国独特的中草药之一,因此优化金线莲提取物的制备工艺,提高其应用价值对充分开发金线莲资源具重要的意义。The currently disclosed preparation process of Anomatis is relatively complex and is not suitable for large-scale production. In addition, the active ingredient content or biological activity obtained by some preparation processes is low, and the active ingredients are unstable, etc., which will cause a waste of Anomatis resources to a certain extent. Anomatis is known as the "King of Medicines" and "Golden Grass" and is one of the unique Chinese herbal medicines in my country. Therefore, optimizing the preparation process of Anomatis extract and improving its application value are important for fully developing Anomatis resources. significance.
申请内容Application content
本申请实施例提供一种金线莲提取物及其制备工艺、应用,以解决相关技术存在的问题,技术方案如下:The embodiments of this application provide a Anomatis extract and its preparation process and application to solve the problems existing in related technologies. The technical solutions are as follows:
第一方面,本申请实施例提供了一种金线莲提取物制备工艺,包括:In the first aspect, the embodiments of the present application provide a preparation process for Anomatis extract, including:
将干燥的金线莲全株用粉碎机粉碎后过筛,得到干粉;Crush the dried Anoectochilus whole plant with a grinder and then sieve to obtain dry powder;
将干粉加入到乙醇溶剂中,进行常温超声提取,得到金线莲粗提液;Add the dry powder to the ethanol solvent and carry out ultrasonic extraction at room temperature to obtain a crude extract of Anomatis;
将金线莲粗提液过滤以除去渣滓,得到滤液;Filter the crude extract of Anomatis to remove residues and obtain a filtrate;
将所得滤液进行膜分离和/或减压浓缩除去乙醇,定容得到浓缩液;The obtained filtrate is subjected to membrane separation and/or concentration under reduced pressure to remove ethanol, and the volume is adjusted to obtain a concentrated solution;
在所得浓缩液中加入助溶剂和稳定剂,之后进行脱色,得到金线莲脱色液;Add a co-solvent and a stabilizer to the obtained concentrated liquid, and then perform decolorization to obtain a Anomatis decolorizing liquid;
将金线莲脱色液过滤、除菌;Filter and sterilize the Anomatis decolorizing solution;
将除菌后的溶液添加防腐剂,即得到金线莲提取物。Add preservatives to the sterilized solution to obtain anomatis extract.
在一种实施方式中,将干粉按料液比1:4-1:40加入到乙醇溶剂中,进行常温超声提取;其中,乙醇溶剂的体积分数为5%-70%,超声频率为480W,超声提取时间为10-60min,提取次数1-2次。In one embodiment, the dry powder is added to the ethanol solvent according to the material-to-liquid ratio of 1:4-1:40, and ultrasonic extraction is performed at room temperature; wherein, the volume fraction of the ethanol solvent is 5%-70%, and the ultrasonic frequency is 480W. The ultrasonic extraction time is 10-60 minutes, and the number of extractions is 1-2 times.
在一种实施方式中,定容至金线莲干粉10-20倍质量,得到浓缩液。In one embodiment, the volume is adjusted to 10-20 times the mass of Anomatis dry powder to obtain a concentrated solution.
在一种实施方式中,在所得浓缩液中加入20%-50%w/w的助溶剂和0.1%-5%w/w的稳定剂。In one embodiment, 20%-50% w/w co-solvent and 0.1%-5% w/w stabilizer are added to the obtained concentrated liquid.
在一种实施方式中,所述助溶剂为甘油、1,3-丙二醇、1,3-丁二醇的一种或几种;In one embodiment, the co-solvent is one or more of glycerol, 1,3-propanediol, and 1,3-butanediol;
所述稳定剂为1,2-己二醇、1,2-戊二醇、对羟基苯乙酮的一种或几种。The stabilizer is one or more of 1,2-hexanediol, 1,2-pentanediol and p-hydroxyacetophenone.
在一种实施方式中,用大孔吸附树脂进行吸附脱色,树脂使用量为4%-40%w/v。In one embodiment, macroporous adsorption resin is used for adsorption and decolorization, and the amount of resin used is 4%-40% w/v.
在一种实施方式中,所述大孔吸附树脂包括D101、AB-8、XAD-2、HDP-100、HP-10、LSD-20中的一种或几种;In one embodiment, the macroporous adsorption resin includes one or more of D101, AB-8, XAD-2, HDP-100, HP-10, and LSD-20;
吸附方式为静态吸附,吸附时间0.5-8h。The adsorption method is static adsorption, and the adsorption time is 0.5-8h.
在一种实施方式中,将除菌后的溶液添加0.1%-0.5%w/w的防腐剂;所述防腐剂为焦亚硫酸钠、苯氧乙醇、苯甲醇、山梨酸钾、山梨酸钠中的一种或几种。In one embodiment, 0.1%-0.5% w/w preservative is added to the sterilized solution; the preservative is sodium metabisulfite, phenoxyethanol, benzyl alcohol, potassium sorbate, and sodium sorbate. One or several.
第二方面,本申请实施例提供了一种金线莲提取物,所述金线莲提取物由上述任一项所述的金线莲提取物制备工艺制备而成。In a second aspect, embodiments of the present application provide a Anomatis extract, which is prepared by any one of the above-described preparation processes for Anomatis extract.
第三方面,本申请实施例提供了一种金线莲提取物的应用,该应用为所述的金线莲提取物在舒缓抗炎、或抗皱、或修护方面的护肤产品中的应用。In a third aspect, the embodiments of the present application provide an application of a Anomatis extract, which is an application of the Anomatis extract in skin care products for soothing, anti-inflammation, anti-wrinkle, or repair.
上述技术方案中的优点或有益效果至少包括:The advantages or beneficial effects of the above technical solutions include at least:
(1)本申请经过优化的提取工艺,包括提取料液比、提取溶剂、提取时间、脱色工艺、增加稳定剂等对金线莲进行提取,得到金线莲提取物,其提取工艺简单高效,适合规模化生产。(1) The optimized extraction process of this application, including extraction material-liquid ratio, extraction solvent, extraction time, decolorization process, adding stabilizer, etc., is used to extract Anomatis chinensis to obtain Anomatis chinensis extract. The extraction process is simple and efficient. Suitable for large-scale production.
(2)采用超声萃取法萃取金线莲植物,使植物细胞壁及整个生物体的破裂在瞬间完成,缩短了破碎时间,同时超声波产生的振动作用加强了金线莲胞内物质的释放、扩散和溶解,从而显著提高提取效率并获得有效成分含量高且性质稳定的金线莲提取物。(2) The ultrasonic extraction method is used to extract the Anomatis plant, so that the rupture of the plant cell wall and the entire organism is completed in an instant, shortening the crushing time. At the same time, the vibration generated by the ultrasonic waves strengthens the release, diffusion and release of intracellular substances of Anomatis. Dissolve, thereby significantly improving the extraction efficiency and obtaining a Anomatis extract with high content of active ingredients and stable properties.
(3)采用本申请获得的金线莲提取物同时富集了多种有效成分如金线莲苷、金线莲多糖等。提取物的性质稳定、有效成分多糖含量高、提取物活性好,具有显著的舒缓抗炎、抗皱、修护功效,可作为皮肤保护剂在护肤品中使用,从而实现金线莲的高值化利用。(3) The Anomatis extract obtained by this application is simultaneously enriched with a variety of active ingredients such as Anomatis glycosides, Anoectochus polysaccharides, etc. The nature of the extract is stable, the active ingredient polysaccharide content is high, the extract activity is good, and it has significant soothing, anti-inflammatory, anti-wrinkle, and repair effects. It can be used as a skin protectant in skin care products, thereby realizing the high value of Anoectochus use.
上述概述仅仅是为了说明书的目的,并不意图以任何方式进行限制。除上述描述的示意性的方面、实施方式和特征之外,通过参考附图和以下的详细描述,本申请进一步的方面、实施方式和特征将会是容易明白的。The above summary is for illustration purposes only and is not intended to be limiting in any way. In addition to the illustrative aspects, embodiments and features described above, further aspects, embodiments and features of the present application will be readily apparent by reference to the drawings and the following detailed description.
附图说明Description of the drawings
在附图中,除非另外规定,否则贯穿多个附图相同的附图标记表示相同或相似的部件或元素。这些附图不一定是按照比例绘制的。应该理解,这些附图仅描绘了根据本申请公开的一些实施方式,而不应将其视为是对本申请范围的限制。In the drawings, unless otherwise specified, the same reference numbers refer to the same or similar parts or elements throughout the several figures. The drawings are not necessarily to scale. It should be understood that these drawings depict only some embodiments disclosed in accordance with the present application and should not be considered as limiting the scope of the present application.
图1显示出了实施例1的金线莲提取物降低RAW264.7细胞炎症因子TNF-α的表达水平的结果图。Figure 1 shows the result of the Anoectochilus extract of Example 1 reducing the expression level of the inflammatory factor TNF-α in RAW264.7 cells.
图2显示出了实施例1的金线莲提取物降低RAW264.7细胞炎症因子IL-1α的表达水平的结果图。Figure 2 shows the result of the Anoectochilus extract of Example 1 reducing the expression level of the inflammatory factor IL-1α in RAW264.7 cells.
图3显示出了实施例1的金线莲提取物促进I型胶原蛋白的合成的结果图。Figure 3 shows the results of the anoectochilus extract in Example 1 promoting the synthesis of type I collagen.
图4显示出了实施例1的金线莲提取物HaCaT细胞增殖实验结果图。Figure 4 shows a graph showing the results of the HaCaT cell proliferation experiment using the Anomatis extract in Example 1.
图5显示出了实施例1的金线莲提取物HaCaT细胞迁移实验imageJ定量分析图。Figure 5 shows the imageJ quantitative analysis diagram of the HaCaT cell migration experiment of the Anomatis extract in Example 1.
图6显示出了实施例1的金线莲提取物HaCaT细胞迁移迁移率柱状图。Figure 6 shows a histogram of the migration mobility of HaCaT cells derived from Anomatis chinensis extract in Example 1.
具体实施方式Detailed ways
在下文中,仅简单地描述了某些示例性实施例。正如本领域技术人员可认识到的那样,在不脱离本申请的精神或范围的情况下,可通过各种不同方式修改所描述的实施例。因此,附图和描述被认为本质上是示例性的而非限制性的。下述实施例中所用的试验方法如无特殊说明,均为常规方法,所使用的原料、试剂等,如无特殊说明,均可从常规市购等商业途径得到。In the following, only certain exemplary embodiments are briefly described. As those skilled in the art would realize, the described embodiments may be modified in various different ways without departing from the spirit or scope of the application. Accordingly, the drawings and description are to be regarded as illustrative in nature and not restrictive. Unless otherwise stated, the test methods used in the following examples are all conventional methods. The raw materials, reagents, etc. used, unless otherwise stated, can be obtained from conventional commercial sources such as commercial sources.
第一方面,本申请实施例提供了一种金线莲提取物制备工艺,包括:In the first aspect, the embodiments of the present application provide a preparation process for Anomatis extract, including:
步骤101,粉碎。Step 101, crush.
将干燥的金线莲全株用粉碎机粉碎后过筛,得到干粉。The dried whole Anomatis plant is crushed with a grinder and then sieved to obtain dry powder.
步骤102,提取。Step 102, extraction.
将干粉加入到乙醇溶剂中,进行常温超声提取,得到金线莲粗提液。The dry powder is added to the ethanol solvent, and ultrasonic extraction is performed at room temperature to obtain a crude extract of Anoectochilus.
在一种实施方式中,将干粉按料液比1:4-1:40加入到乙醇溶剂中,进行常温超声提取;其中,乙醇溶剂的体积分数为5%-70%,超声频率为480W,超声提取时间为10-60min,提取次数1-2次。In one embodiment, the dry powder is added to the ethanol solvent according to the material-to-liquid ratio of 1:4-1:40, and ultrasonic extraction is performed at room temperature; wherein, the volume fraction of the ethanol solvent is 5%-70%, and the ultrasonic frequency is 480W. The ultrasonic extraction time is 10-60 minutes, and the number of extractions is 1-2 times.
超声对萃取的强化主动力来源于超声空化效应,超声空化过程是集中声场能量并迅即释放的过程,通常是指液体中的存在的微小气泡在超声波的作用下被激活所表现出的振荡、生长、收缩、崩溃等一系列动力学过程。超声空化引起了湍动效应、微扰效应、界面效应和聚能效应等。湍动效应使边界层减薄,增大传质速率;微扰效应强化了微孔扩散;界面效应增大了传质表面积;聚能效应活化了分离物质分子;从而整体上强化了分离纯化过程的传质速率和效果。超声提取中药材不受成分极性、分子量大小的限制,适用于绝大多数种类中药材和各类成分的提取;提取药液,有效成分易于分离、纯化;在整个萃取过程中没有化学反应,对活性成分的活性影响很小。超声萃取能缩短萃取时间,提高萃取率,与常规方法相比,超声萃取法有操作简单、提取时间短、提取效率较高及无需加热的优点。The main driving force of ultrasound to enhance extraction comes from the ultrasonic cavitation effect. The ultrasonic cavitation process is a process that concentrates the sound field energy and releases it quickly. It usually refers to the oscillation caused by the tiny bubbles in the liquid being activated under the action of ultrasonic waves. , growth, shrinkage, collapse and a series of dynamic processes. Ultrasonic cavitation causes turbulence effects, perturbation effects, interface effects and energy concentration effects, etc. The turbulence effect thins the boundary layer and increases the mass transfer rate; the perturbation effect strengthens the micropore diffusion; the interface effect increases the mass transfer surface area; the concentrated energy effect activates the separated material molecules; thereby strengthening the separation and purification process as a whole mass transfer rate and effect. Ultrasonic extraction of Chinese medicinal materials is not limited by the polarity and molecular weight of the ingredients, and is suitable for the extraction of most types of Chinese medicinal materials and various components. When extracting medicinal liquids, the active ingredients are easy to separate and purify; there is no chemical reaction during the entire extraction process. Little effect on the activity of the active ingredients. Ultrasonic extraction can shorten the extraction time and improve the extraction rate. Compared with conventional methods, ultrasonic extraction has the advantages of simple operation, short extraction time, high extraction efficiency and no need for heating.
采用超声萃取法萃取金线莲植物,使植物细胞壁及整个生物体的破裂在瞬间完成,缩短了破碎时间,同时超声波产生的振动作用加强了金线莲胞内物质的释放、扩散和溶解,从而显著提高提取效率并获得有效成分含量高且性质稳定的金线莲提取物。The ultrasonic extraction method is used to extract the Anomatis plant, so that the rupture of the plant cell wall and the entire organism is completed in an instant, shortening the crushing time. At the same time, the vibration generated by the ultrasonic waves strengthens the release, diffusion and dissolution of the intracellular substances of Anomatis, thereby Significantly improve the extraction efficiency and obtain a Anomatis extract with high content of active ingredients and stable properties.
步骤103,过滤。Step 103, filter.
将金线莲粗提液过滤以除去渣滓,得到滤液。Filter the crude extract of Anomatis to remove residues and obtain a filtrate.
步骤104,浓缩定容。Step 104: Concentrate to volume.
将所得滤液进行膜分离和/或减压浓缩除去乙醇,定容得到浓缩液。The obtained filtrate is subjected to membrane separation and/or concentration under reduced pressure to remove ethanol, and the volume is adjusted to obtain a concentrated solution.
在一种实施方式中,定容至金线莲干粉10-20倍质量,得到浓缩液。In one embodiment, the volume is adjusted to 10-20 times the mass of Anomatis dry powder to obtain a concentrated solution.
步骤105,溶解及脱色。Step 105, dissolve and decolorize.
在所得浓缩液中加入助溶剂和稳定剂,之后进行脱色,得到金线莲脱色液。A co-solvent and a stabilizer are added to the obtained concentrated liquid, and then decolorized to obtain a Anomatis decolorizing liquid.
由于在步骤104中,提取物会有微量不溶于水的沉淀析出,添加助溶剂可溶解沉淀,添加稳定剂可稳定加热浓缩过程导致提取物发生物理如颜色方面的变化。此步骤可提高提取物的稳定性、提高质量如颜色、提高溶解性等。Since in step 104, a trace amount of water-insoluble precipitate will precipitate out of the extract, adding a co-solvent can dissolve the precipitate, and adding a stabilizer can stabilize the heating and concentration process, resulting in physical changes in the extract such as color. This step improves the stability of the extract, improves quality such as color, improves solubility, etc.
在一种实施方式中,在所得浓缩液中加入20%-50%w/w的助溶剂和In one embodiment, 20%-50% w/w co-solvent and
0.1%-5%w/w的稳定剂。0.1%-5% w/w stabilizer.
在一种实施方式中,所述助溶剂为甘油、1,3-丙二醇、1,3-丁二醇的一种或几种。In one embodiment, the co-solvent is one or more of glycerol, 1,3-propanediol, and 1,3-butanediol.
在一种实施方式中,所述稳定剂为1,2-己二醇、1,2-戊二醇、对羟基苯乙酮的一种或几种。In one embodiment, the stabilizer is one or more of 1,2-hexanediol, 1,2-pentanediol, and p-hydroxyacetophenone.
在一种实施方式中,用大孔吸附树脂进行吸附脱色,树脂使用量为4%-40%w/v。In one embodiment, macroporous adsorption resin is used for adsorption and decolorization, and the amount of resin used is 4%-40% w/v.
在一种实施方式中,所述大孔吸附树脂包括D101、AB-8、XAD-2、HDP-100、HP-10、LSD-20中的一种或几种。In one embodiment, the macroporous adsorption resin includes one or more of D101, AB-8, XAD-2, HDP-100, HP-10, and LSD-20.
在一种实施方式中,吸附方式为静态吸附,吸附时间0.5-8h。In one embodiment, the adsorption method is static adsorption, and the adsorption time is 0.5-8 hours.
步骤106,除菌。Step 106, sterilization.
将金线莲脱色液过滤、除菌。Filter and sterilize the Anoectochilus decolorizing solution.
步骤107,添加防腐剂。Step 107, add preservative.
将除菌后的溶液添加防腐剂,即得到金线莲提取物。Add preservatives to the sterilized solution to obtain anomatis extract.
在一种实施方式中,将除菌后的溶液添加0.1%-0.5%w/w的防腐剂;所述防腐剂为焦亚硫酸钠、苯氧乙醇、苯甲醇、山梨酸钾、山梨酸钠中的一种或几种。In one embodiment, 0.1%-0.5% w/w preservative is added to the sterilized solution; the preservative is sodium metabisulfite, phenoxyethanol, benzyl alcohol, potassium sorbate, and sodium sorbate. One or several.
第二方面,本申请实施例提供了一种金线莲提取物,所述金线莲提取物由金线莲提取物制备工艺制备而成。In the second aspect, the embodiments of the present application provide an Anomatis extract, which is prepared by a Anomatis extract preparation process.
第三方面,本申请实施例提供了一种金线莲提取物的应用,该应用为所述的金线莲提取物在舒缓抗炎、或抗皱、或修护方面的护肤产品中的应用。In a third aspect, the embodiments of the present application provide an application of a Anomatis extract, which is an application of the Anomatis extract in skin care products for soothing, anti-inflammation, anti-wrinkle, or repair.
实施例1Example 1
S1、粉碎:取干燥的金线莲全株用粉碎机粉碎后过一号筛,得到20g的金线莲干粉;S1. Grinding: Take the dried whole plant of Anomatis and crush it with a grinder and then pass it through the No. 1 sieve to obtain 20g of Anomatis dry powder;
S2、提取:将S1所得干粉按料液比1:15加入30%的乙醇溶剂进行超声提取1次,超声频率为480W,超声提取时间为30min,得到金线莲粗提液;S2. Extraction: Add 30% ethanol solvent to the dry powder obtained in S1 at a material-to-liquid ratio of 1:15 for ultrasonic extraction once. The ultrasonic frequency is 480W and the ultrasonic extraction time is 30 minutes to obtain a crude extract of Anoectochilus;
S3、过滤:过滤S2所得金线莲粗提液以除去渣滓;S3. Filtration: Filter the crude extract of Anomatis obtained in S2 to remove residue;
S4、浓缩:将S3所得滤液减压浓缩除去乙醇,用水定容至金线莲干粉10倍质量;S4. Concentration: Concentrate the filtrate obtained in S3 under reduced pressure to remove ethanol, and dilute the volume with water to 10 times the mass of Anoectochilus dry powder;
S5、溶解:在S4所得的浓缩液中加入甘油、1,2-己二醇、对羟基苯乙酮,终溶液为生药:溶液=1:20质量比,组成成分为48.6%w/w浓缩液,50%w/w甘油,0.7%w/w1,2-己二醇和0.7%w/w对羟基苯乙酮;S5. Dissolve: Add glycerol, 1,2-hexanediol, and p-hydroxyacetophenone to the concentrated solution obtained in S4. The final solution is a crude drug: solution = 1:20 mass ratio, and the composition is 48.6% w/w concentrated Liquid, 50% w/w glycerol, 0.7% w/w 1,2-hexanediol and 0.7% w/w p-hydroxyacetophenone;
S6、脱色:对S5所得溶液用20%w/w的XAD-2大孔吸附树脂进行吸附脱色2h,得到金线莲脱色液;S6. Decolorization: Use 20% w/w XAD-2 macroporous adsorption resin for adsorption and decolorization of the solution obtained in S5 for 2 hours to obtain a Anomatis decolorization liquid;
S7、除菌:将S6所述脱色液过滤除菌;S7. Sterilization: filter and sterilize the decolorizing liquid described in S6;
S8、防腐复配:将S7除菌后的溶液添加0.1%w/w焦亚硫酸钠,即得到金线莲提取物。S8. Antiseptic compounding: Add 0.1% w/w sodium metabisulfite to the sterilized solution of S7 to obtain anomatis extract.
助溶剂选用甘油、1,3-丙二醇、1,3-丁二醇,均可与水或乙醇混溶。Glycerol, 1,3-propanediol, and 1,3-butanediol are used as co-solvents, all of which are miscible with water or ethanol.
在金线莲提取物的制备过程中,浓缩除去乙醇后有不溶于水的活性物析出,添加甘油、1,3-丙二醇、1,3-丁二醇作为助溶剂可溶解。In the preparation process of Anoectochilus extract, after concentration and removal of ethanol, water-insoluble active substances precipitate, which can be dissolved by adding glycerin, 1,3-propylene glycol, and 1,3-butanediol as co-solvents.
1,2-己二醇、1,2-戊二醇由于分子结构中含有2个羟基亲水基团和直链烷基疏水基团,因而具有油水两亲性。金线莲提取物制备过程中,浓缩除去乙醇后有微量不溶于水的沉淀析出,添加1,2-己二醇、1,2-戊二醇作为助溶剂可溶解。验证实验结果如下:1,2-hexanediol and 1,2-pentanediol have oil-water amphipathic properties because their molecular structures contain two hydroxyl hydrophilic groups and linear alkyl hydrophobic groups. During the preparation process of the Anomatis extract, after concentration and removal of ethanol, a trace amount of water-insoluble precipitate precipitates, which can be dissolved by adding 1,2-hexanediol and 1,2-pentanediol as co-solvents. The verification experiment results are as follows:
表1 1,2-己二醇、1,2-戊二醇添加量对金线莲提取物澄清度的影响Table 1 Effect of the addition of 1,2-hexanediol and 1,2-pentanediol on the clarity of Anomatis extract
本实施例中选用对羟基苯乙酮作为稳定剂。对羟基苯乙酮是一种抗氧化剂,可抑制植物提取物中酚类等色素氧化变色。金线莲提取物制备过程中,添加对羟基苯乙酮可抑制金线莲提取物变色。验证实验结果如下:In this embodiment, p-hydroxyacetophenone is selected as the stabilizer. Parahydroxyacetophenone is an antioxidant that can inhibit the oxidative discoloration of phenols and other pigments in plant extracts. During the preparation process of Anomatis extract, the addition of p-hydroxyacetophenone can inhibit the discoloration of Anomatis extract. The verification experiment results are as follows:
表2对羟基苯乙酮添加量对金线莲提取物色泽的影响Table 2 Effect of the added amount of p-hydroxyacetophenone on the color of Anomatis extract
实施例2Example 2
S1、粉碎:取干燥的金线莲全株用粉碎机粉碎后过四号筛,得到50g的金线莲干粉;S1. Crushing: Take the dried whole plant of Anomatis and grind it with a grinder and then pass it through the No. 4 sieve to obtain 50g of Anoectochilus dry powder;
S2、提取:将S1所得干粉按料液比1:20加入10%的乙醇溶剂进行超声提取2次,超声频率为480W,超声提取时间为30min,合并金线莲粗提液;S2. Extraction: Add 10% ethanol solvent to the dry powder obtained in S1 according to the material-to-liquid ratio of 1:20 for ultrasonic extraction twice. The ultrasonic frequency is 480W and the ultrasonic extraction time is 30 minutes. Combine the crude extract of Anoectochilus;
S3、过滤:过滤S2所得金线莲粗提液以除去渣滓;S3. Filtration: Filter the crude extract of Anomatis obtained in S2 to remove residue;
S4、浓缩:将S3所得滤液减压浓缩除去乙醇,用水定容至金线莲干粉15倍质量;S4. Concentration: Concentrate the filtrate obtained in S3 under reduced pressure to remove ethanol, and dilute the volume with water to 15 times the mass of Anoectochilus dry powder;
S5、溶解:在S4所得的浓缩液中加入1,3-丙二醇、1,2-戊二醇、对羟基苯乙酮,终溶液为生药:溶液=1:20质量比,组成成分为68.6%w/w浓缩液,30%w/w1,3-丙二醇,0.7%w/w1,2-戊二醇和0.7%w/w对羟基苯乙酮;S5. Dissolution: Add 1,3-propanediol, 1,2-pentanediol, and p-hydroxyacetophenone to the concentrated solution obtained in S4. The final solution is a crude drug: solution = 1:20 mass ratio, composition is 68.6% w/w concentrate, 30% w/w 1,3-propanediol, 0.7% w/w 1,2-pentanediol and 0.7% w/w p-hydroxyacetophenone;
S6、脱色:对S5所得溶液用20%w/w的D101大孔吸附树脂进行吸附脱色4h,得到金线莲脱色液;S6. Decolorization: Use 20% w/w D101 macroporous adsorption resin to adsorb and decolorize the solution obtained in S5 for 4 hours to obtain a Anomatis decolorizing liquid;
S7、除菌:将S6所述脱色液过滤除菌;S7. Sterilization: filter and sterilize the decolorizing liquid described in S6;
S8、防腐复配:将S7除菌后的溶液添加0.5%w/w山梨酸钾,即得到金线莲提取物。S8. Preservative compounding: Add 0.5% w/w potassium sorbate to the sterilized solution of S7 to obtain anomatis extract.
实施例3Example 3
S1、粉碎:取干燥的金线莲全株用粉碎机粉碎后过二号筛,得到100g的金线莲干粉;S1. Crushing: Take the dried whole plant of Anomatis and crush it with a grinder and then pass it through the No. 2 sieve to obtain 100g of Anoectochilus dry powder;
S2、提取:将S1所得干粉按料液比1:10加入50%的乙醇溶剂进行超声提取2次,超声频率为480W,超声提取时间为10min,合并金线莲粗提液;S2. Extraction: Add 50% ethanol solvent to the dry powder obtained in S1 at a material-to-liquid ratio of 1:10 for ultrasonic extraction twice. The ultrasonic frequency is 480W and the ultrasonic extraction time is 10 minutes. Combine the crude extract of Anoectochilus;
S3、过滤:过滤S2所得金线莲粗提液以除去渣滓;S3. Filtration: Filter the crude extract of Anomatis obtained in S2 to remove residue;
S4、浓缩:将S3所得滤液减压浓缩除去乙醇,用水定容至金线莲干粉10倍质量;S4. Concentration: Concentrate the filtrate obtained in S3 under reduced pressure to remove ethanol, and dilute the volume with water to 10 times the mass of Anoectochilus dry powder;
S5、溶解:在S4所得的浓缩液中加入1,3-丁二醇、1,2-己二醇、对羟基苯乙酮,终溶液为生药:溶液=1:20质量比,组成成分为68.6%w/w浓缩液,30%w/w1,3-丁二醇,0.7%w/w1,2-己二醇和0.7%w/w对羟基苯乙酮;S5. Dissolution: Add 1,3-butanediol, 1,2-hexanediol, and p-hydroxyacetophenone to the concentrated solution obtained in S4. The final solution is a crude drug: solution = 1:20 mass ratio, and the composition is: 68.6% w/w concentrate, 30% w/w 1,3-butanediol, 0.7% w/w 1,2-hexanediol and 0.7% w/w p-hydroxyacetophenone;
S6、脱色:对S5所得溶液用10%w/w的AB-8和HP-10大孔吸附树脂进行吸附脱色2h,得到金线莲脱色液;S6. Decolorization: Use 10% w/w AB-8 and HP-10 macroporous adsorption resin for adsorption and decolorization of the solution obtained in S5 for 2 hours to obtain a Anomatis decolorization solution;
S7、除菌:将S6所述脱色液过滤除菌;S7. Sterilization: filter and sterilize the decolorizing liquid described in S6;
S8、防腐复配:将S7除菌后的溶液添加0.5%w/w苯甲酸,即得到金线莲提取物。S8. Preservative compounding: Add 0.5% w/w benzoic acid to the sterilized solution of S7 to obtain anomatis extract.
对照例Comparative example
本对照例除了S2中超声提取、S5中加助溶剂和稳定剂与实施例1不同之外,其他工艺与实施例1相同。This comparative example is different from Example 1 except for the ultrasonic extraction in S2 and the addition of co-solvent and stabilizer in S5. The other processes are the same as Example 1.
S1、粉碎:取干燥的金线莲全株用粉碎机粉碎后过一号筛,得到20g的金线莲干粉;S1. Grinding: Take the dried whole plant of Anomatis and crush it with a grinder and then pass it through the No. 1 sieve to obtain 20g of Anomatis dry powder;
S2、提取:将S1所得干粉按料液比1:15加入30%的乙醇溶剂浸泡提取1次,得到金线莲粗提液;S2. Extraction: Add the dry powder obtained in S1 to 30% ethanol solvent at a material-to-liquid ratio of 1:15 and soak it for extraction once to obtain a crude extract of Anoectochilus;
S3、过滤:过滤S2所得金线莲粗提液以除去渣滓;S3. Filtration: Filter the crude extract of Anomatis obtained in S2 to remove residue;
S4、浓缩:将S3所得滤液减压浓缩除去乙醇,用水定容至金线莲干粉10倍质量;S4. Concentration: Concentrate the filtrate obtained in S3 under reduced pressure to remove ethanol, and dilute the volume with water to 10 times the mass of Anoectochilus dry powder;
S5、溶解:在S4所得的浓缩液中加入纯水,终溶液为生药:溶液=1:20质量比,组成成分为50%w/w浓缩液,50%w/w水;S5. Dissolution: Add pure water to the concentrated solution obtained in S4. The final solution is a crude drug: solution = 1:20 mass ratio, composed of 50% w/w concentrated solution and 50% w/w water;
S6、脱色:对S5所得溶液用20%w/w的XAD-2大孔吸附树脂进行吸附脱色2h,得到金线莲脱色液;S6. Decolorization: Use 20% w/w XAD-2 macroporous adsorption resin for adsorption and decolorization of the solution obtained in S5 for 2 hours to obtain a Anomatis decolorization liquid;
S7、除菌:将S6所述脱色液过滤除菌,即得到金线莲提取物;S7. Sterilization: Filter and sterilize the decolorizing liquid described in S6 to obtain Anomatis extract;
S8、防腐复配:将S7除菌后的溶液添加0.1%w/w焦亚硫酸钠,即得到金线莲提取物。S8. Antiseptic compounding: Add 0.1% w/w sodium metabisulfite to the sterilized solution of S7 to obtain anomatis extract.
实施例1-3和对照例金线莲提取物多糖含量对比实验Comparative experiment on the polysaccharide content of the Anomatis extracts of Examples 1-3 and the comparative example
表3实施例1-3和对照例金线莲提取物多糖含量对比Table 3 Comparison of polysaccharide content of Anoectochilus extracts between Examples 1-3 and Comparative Examples
由表3可知,采用超声法提取的金线莲多糖含量较高。It can be seen from Table 3 that the polysaccharide content of Anoectochilus extracted using ultrasonic method is relatively high.
实施例1-3和对照例金线莲提取物的稳定性测试Stability test of Anomatis extracts in Examples 1-3 and Comparative Examples
参照TSHFCA002-2021化妆品稳定性试验指导原则对本申请工艺获得的金线莲提取物进行稳定测试。在45℃±2℃、相对湿度45%RH±5%RH的条件下进行6个月试验,考察项目为外观、气味、pH值、金线莲多糖含量,测试标准见下表4:The stability test of the Anomatis extract obtained by the process of this application was carried out with reference to the TSHFCA002-2021 Cosmetic Stability Test Guidelines. The test was carried out for 6 months under the conditions of 45℃±2℃ and relative humidity of 45%RH±5%RH. The inspection items were appearance, smell, pH value, and Anoectochus polysaccharide content. The test standards are shown in Table 4 below:
表4金线莲提取物的稳定性测试Table 4 Stability test of Anomatis extract
依照设计的稳定性测试试验方案,进行了加速试验,本次结果为6个月的加速试验结果(表5)。According to the designed stability test plan, an accelerated test was conducted, and the results are the 6-month accelerated test results (Table 5).
表5金线莲提取物的稳定性测试结果Table 5 Stability test results of Anomatis extract
由表5可知,本申请的工艺所得的金线莲提取物,在原料外观、气味、pH值、相对密度、微生物以及金线莲多糖含量这些质控指标上均符合标准要求的范围,与对照例比较,其在理化性质和有效成分含量不会随时间的变化发生明显改变,从而保证了金线莲提取物本身的活性。As can be seen from Table 5, the quality control indicators of the Anoectochus extract obtained by the process of the present application are within the scope of the standard requirements in terms of raw material appearance, odor, pH value, relative density, microorganisms, and Anoectochus polysaccharide content, and are consistent with the control. Compared with other examples, its physical and chemical properties and active ingredient content will not change significantly over time, thus ensuring the activity of the Anoectochilus extract itself.
金线莲提取物的舒缓抗炎效果测试Test of soothing and anti-inflammatory effects of Anomatis extract
通过脂多糖(LPS)诱导巨噬细胞RAW264.7炎症模型,对RAW264.7细胞炎症因子TNF-α和IL-1α水平进行检测,观察金线莲提取物的抗炎作用。按7×105个/孔,将培养好的细胞接种在6孔板中,每孔2mL,放入5%CO2培养箱,37℃恒温培养24h;去掉上清,给药2mL,模型组;5μg/mL脂多糖(LPS);样品组:5μg/mL脂多糖(LPS)+本申请的金线莲提取物;空白对照组:加入无血清培养基;放入CO2培养箱(37℃、5%CO2)继续培养24h;吸取上清,按照试剂盒说明书进行操作。Through lipopolysaccharide (LPS)-induced macrophage RAW264.7 inflammation model, the levels of inflammatory factors TNF-α and IL-1α in RAW264.7 cells were detected to observe the anti-inflammatory effect of Anoectochilus extract. Inoculate the cultured cells in a 6-well plate at 7 × 10 5 cells/well, 2 mL per well, place in a 5% CO 2 incubator, and incubate at 37°C for 24 hours; remove the supernatant and administer 2 mL to the model group ; 5 μg/mL lipopolysaccharide (LPS); sample group: 5 μg/mL lipopolysaccharide (LPS) + anoectochilus extract of the present application; blank control group: add serum-free culture medium; place in CO 2 incubator (37°C , 5% CO 2 ) and continue culturing for 24 hours; aspirate the supernatant and operate according to the instructions of the kit.
如图1和图2结果所示,Control:空白对照组;Model:5μg/mL LPS诱导模型组;阳性对照组:100μg/mL DXMS(地塞米松);实验组:高中低剂量金线莲提取物,JXL-H,5μg/mLLPS+10%金线莲提取物;JXL-M,5μg/mL LPS+5%金线莲提取物;JXL-L,5μg/mL LPS+2.5%金线莲提取物。#表示与Control相比具有显著性差异(P<0.05);*表示与Model相比具有显著性差异(P<0.05)。As shown in the results in Figure 1 and Figure 2, Control: Blank control group; Model: 5 μg/mL LPS induction model group; Positive control group: 100 μg/mL DXMS (dexamethasone); Experimental group: Anoectochilus extract at high, medium and low doses Materials, JXL-H, 5μg/mLLPS + 10% Anoectochilus extract; JXL-M, 5μg/mL LPS + 5% Anomatis extract; JXL-L, 5μg/mL LPS + 2.5% Anomatis extract things. # indicates a significant difference compared with Control (P<0.05); * indicates a significant difference compared with Model (P<0.05).
Control:空白对照组;Model:5μg/mL LPS诱导组;阳性对照组:100μg/mLDXMS(地塞米松);实验组:高中低剂量金线莲提取物,JXL-H,5μg/mL LPS+1%金线莲提取物;JXL-M,5μg/mL LPS+0.5%金线莲提取物;JXL-L,5μg/mLLPS+0.1%金线莲提取物。#表示与Control相比具有显著性差异(P<0.05);*表示与Model相比具有显著性差异(P<0.05)。Control: Blank control group; Model: 5 μg/mL LPS induction group; Positive control group: 100 μg/mL DXMS (dexamethasone); Experimental group: High, high, and low-dose Anomatis extract, JXL-H, 5 μg/mL LPS+1 % Anomatis extract; JXL-M, 5 μg/mL LPS + 0.5% Anomatis extract; JXL-L, 5 μg/mLLPS + 0.1% Anomatis extract. # indicates a significant difference compared with Control (P<0.05); * indicates a significant difference compared with Model (P<0.05).
与空白对照组(Control)相比,模型组(Model)的TNF-α、IL-1α的含量水平显著升高,说明炎症细胞模型建立成功。金线莲提取物对由LPS诱导RAW264.7细胞的TNF-α分泌有显著的抑制作用;同时,金线莲提取物对由LPS诱导RAW264.7细胞的IL-1α分泌也有显著的抑制作用,且呈剂量依赖性。由此说明,本申请的金线莲提取物具有良好的抗炎作用,适用于舒缓类的皮肤护理产品中。Compared with the blank control group (Control), the content levels of TNF-α and IL-1α in the model group (Model) were significantly increased, indicating that the inflammatory cell model was successfully established. Anoectochilus extract has a significant inhibitory effect on the TNF-α secretion of RAW264.7 cells induced by LPS; at the same time, Anoectochilus extract also has a significant inhibitory effect on the IL-1α secretion of RAW264.7 cells induced by LPS. And it is dose-dependent. This shows that the anoectochilus extract of the present application has good anti-inflammatory effects and is suitable for use in soothing skin care products.
金线莲提取物的抗皱效果测试Test on the anti-wrinkle effect of Anomatis extract
将处于对数生长期的人皮肤成纤维细胞(HSF)重悬计数后,按照2.5×105/孔的密度接种到6孔细胞培养板中,放入CO2培养箱,37℃培养24h;待细胞贴壁后,去掉原培养液,每孔加药2mL;实验分组设计为Control(空白对照组),加入含1%血清培养基,不做任何处理;实验组加入用含1%血清DMEM培养基稀释好的本申请的金线莲提取物;放入CO2培养箱,37℃培养24h;然后收集细胞上清液,8000rpm离心10min,取上清按照Human COL1α1(Collagen TypeⅠAlpha 1)ELISA Kit说明书进行操作。After the human skin fibroblasts (HSF) in the logarithmic growth phase were resuspended and counted, they were seeded into a 6-well cell culture plate at a density of 2.5×10 5 /well, placed in a CO 2 incubator, and cultured at 37°C for 24 hours; After the cells adhere to the wall, remove the original culture medium and add 2 mL of medicine to each well; the experimental group design is Control (blank control group), add culture medium containing 1% serum without any treatment; add DMEM containing 1% serum to the experimental group The anoectochilus extract of this application diluted in the culture medium; put it into a CO2 incubator and culture it at 37°C for 24 hours; then collect the cell supernatant, centrifuge it at 8000 rpm for 10 minutes, and take the supernatant according to the instructions of the Human COL1α1 (Collagen Type I Alpha 1) ELISA Kit Perform operations.
实验结果如图3所示,Control:空白对照组;实验组:高中低剂量金线莲提取物,JXL-H,1%(v/v)金线莲提取物;JXL-M,0.5%(v/v)金线莲提取物;JXL-L,0.25%(v/v)金线莲提取物。*表示与Control相比具有显著性差异(P<0.05)。The experimental results are shown in Figure 3. Control: blank control group; experimental group: high, medium and low-dose Alematophila anomatis extract, JXL-H, 1% (v/v) Anoectochilus arunchus extract; JXL-M, 0.5% ( v/v) Anoectochus extract; JXL-L, 0.25% (v/v) Anomatis extract. * indicates significant difference compared with Control (P<0.05).
1%和0.5%浓度的本申请的金线莲提取物显著促进人皮肤成纤维细胞(HSF)合成I型胶原蛋白,与空白对照组相比较,I型胶原蛋白合成提高了20%以上。由此说明,本申请的金线莲提取物适用于抗皱类的皮肤护理产品中。The anoectochilus extract of the present application at concentrations of 1% and 0.5% significantly promotes the synthesis of type I collagen by human skin fibroblasts (HSF). Compared with the blank control group, the synthesis of type I collagen is increased by more than 20%. This shows that the anoectochilus extract of the present application is suitable for use in anti-wrinkle skin care products.
金线莲提取物的修护效果测试Test on the repairing effect of Anomatis extract
(1)细胞增殖试验(1) Cell proliferation test
将人角质形成(HaCaT)细胞按5.0×103/孔接种到96孔板中,每孔100uL,放入CO2培养箱培养12h;弃上清,加入测试药物,空白对照组(Control)加入含1%血清培养基,不做任何处理,竞品对照组为0.1mg/mLNMN,样品组为本申请的金线莲提取物(浓度为1%、0.75%,0.5%、0.25%);培养24h,弃上清,每孔加入含10%CCK-8试剂的完全培养液100uL,孵育1.5h,酶标仪450nm处检测。Human keratinocytes (HaCaT) cells were seeded into a 96-well plate at 5.0×10 3 /well, 100uL per well, and cultured in a CO 2 incubator for 12 hours; discard the supernatant, add test drugs, and add the blank control group (Control) Containing 1% serum culture medium without any treatment, the competitive product control group is 0.1 mg/mL NMN, and the sample group is the Anomatis extract of the present application (concentrations are 1%, 0.75%, 0.5%, 0.25%); culture 24h, discard the supernatant, add 100uL of complete culture medium containing 10% CCK-8 reagent to each well, incubate for 1.5h, and detect at 450nm with a microplate reader.
实验结果如图4显示,与空白对照组相比,竞品对照组与样品组均有一定的促进HaCaT细胞增殖作用,但1%金线莲提取物对HaCaT细胞的促增殖作用更强。The experimental results are shown in Figure 4. Compared with the blank control group, both the competitive control group and the sample group have a certain effect on promoting the proliferation of HaCaT cells, but the 1% Anoectochilus extract has a stronger effect on promoting the proliferation of HaCaT cells.
(2)细胞迁移试验(2) Cell migration test
将人角质形成(HaCaT)细胞按3×105/孔接种到6孔板中,每孔2mL,放入CO2培养箱培养24h;每孔用200μL移液枪头划痕,去掉培养液,用PBS清洗多余的细胞,去掉溶液;加入测试药物,空白对照组(Control)加入含1%血清培养基,不做任何处理,阳性对照组加入10ng/mL EGF,样品组加本申请的金线莲提取物(浓度为1%、0.25%),放入CO2培养箱培养,分别于0h、12h、24h、48h进行拍照记录;进行imageJ定量分析得到迁移面积。Human keratinocytes (HaCaT) cells were seeded into a 6-well plate at 3 × 10 5 /well, 2 mL per well, and cultured in a CO 2 incubator for 24 hours; scratch each well with a 200 μL pipette tip, and remove the culture medium. Wash excess cells with PBS and remove the solution; add test drugs, add culture medium containing 1% serum to the blank control group (Control) without any treatment, add 10ng/mL EGF to the positive control group, and add the gold thread of this application to the sample group Lotus extract (concentration: 1%, 0.25%) was cultured in a CO 2 incubator, and photos were taken and recorded at 0h, 12h, 24h, and 48h respectively; imageJ quantitative analysis was performed to obtain the migration area.
如图5-6所示,HaCaT细胞的迁移率与时间有正相关性,在加药48h时,阳性对照组的迁移率为30.5%;而样品组中,1%金线莲提取物处理,HaCaT细胞的迁移率是23.9%、0.5%金线莲提取物处理,HaCaT细胞的迁移率是16.6%;空白对照组(Control)的迁移率为14.7%,与空白对照组(Control)相比,金线莲提取物均促进了HaCaT细胞的迁移,由此说明本申请的金线莲提取物具有一定的修护功效,适用于修护类的护肤品中。As shown in Figure 5-6, the migration rate of HaCaT cells has a positive correlation with time. At 48 hours after adding the drug, the migration rate of the positive control group was 30.5%; while in the sample group, treated with 1% Anoectochilus extract, The migration rate of HaCaT cells is 23.9%. When treated with 0.5% Anoectochilus extract, the migration rate of HaCaT cells is 16.6%; the migration rate of the blank control group (Control) is 14.7%. Compared with the blank control group (Control), Anomatis extracts all promote the migration of HaCaT cells, which shows that the Anomatis extracts of the present application have a certain repairing effect and are suitable for use in repairing skin care products.
在本说明书的描述中,参考术语“一个实施例”、“一些实施例”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包括于本申请的至少一个实施例或示例中。而且,描述的具体特征、结构、材料或者特点可以在任一个或多个实施例或示例中以合适的方式结合。此外,在不相互矛盾的情况下,本领域的技术人员可以将本说明书中描述的不同实施例或示例以及不同实施例或示例的特征进行结合和组合。In the description of this specification, reference to the terms "one embodiment," "some embodiments," "an example," "specific examples," or "some examples" or the like means that specific features are described in connection with the embodiment or example. , structures, materials or features are included in at least one embodiment or example of the present application. Furthermore, the specific features, structures, materials or characteristics described may be combined in any suitable manner in any one or more embodiments or examples. Furthermore, those skilled in the art may combine and combine different embodiments or examples and features of different embodiments or examples described in this specification unless they are inconsistent with each other.
此外,术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性或者隐含指明所指示的技术特征的数量。由此,限定有“第一”、“第二”的特征可以明示或隐含地包括至少一个该特征。在本申请的描述中,“多个”的含义是两个或两个以上,除非另有明确具体的限定。In addition, the terms “first” and “second” are used for descriptive purposes only and cannot be understood as indicating or implying relative importance or implicitly indicating the quantity of indicated technical features. Thus, features defined as "first" and "second" may explicitly or implicitly include at least one of these features. In the description of this application, "plurality" means two or more than two, unless otherwise explicitly and specifically limited.
以上所述,仅为本申请的具体实施方式,但本申请的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本申请揭露的技术范围内,可轻易想到其各种变化或替换,这些都应涵盖在本申请的保护范围之内。因此,本申请的保护范围应以权利要求的保护范围为准。The above are only specific embodiments of the present application, but the protection scope of the present application is not limited thereto. Any person familiar with the technical field can easily think of various changes or modifications within the technical scope disclosed in the present application. Replacements, these should all be covered by the protection scope of this application. Therefore, the protection scope of this application should be subject to the protection scope of the claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311122467.9A CN116898780B (en) | 2023-08-31 | 2023-08-31 | Aromatic thread vine extract and its preparation process and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311122467.9A CN116898780B (en) | 2023-08-31 | 2023-08-31 | Aromatic thread vine extract and its preparation process and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116898780A true CN116898780A (en) | 2023-10-20 |
CN116898780B CN116898780B (en) | 2024-12-10 |
Family
ID=88360536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311122467.9A Active CN116898780B (en) | 2023-08-31 | 2023-08-31 | Aromatic thread vine extract and its preparation process and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116898780B (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101580554A (en) * | 2009-07-01 | 2009-11-18 | 韩金光 | Anoectochilus roxburghii polyose, applications thereof in pharmacy and preparation method of anoectochilus roxburghii polyose |
US20110082103A1 (en) * | 2009-10-05 | 2011-04-07 | China Medical University | Anoectochilus SPP. polysaccharide extracts for stimulating growth of advantageous bacteria, stimuating release of granulocyte colony-Stimulating factor, modulating T helper cell type I, and/or modulating T helper cell type II and uses of the same |
CN105079466A (en) * | 2014-05-16 | 2015-11-25 | 华中科技大学 | Jinxianlian effervescent tablet and preparation method thereof |
CN105079467A (en) * | 2014-05-16 | 2015-11-25 | 华中科技大学 | Method for extracting anoectochilus roxburghii and application of extracts of anoectochilus roxburghii |
CN106420521A (en) * | 2016-08-30 | 2017-02-22 | 广东丸美生物技术股份有限公司 | Anoectochilus roxburghiiv flavone extraction process and application thereof in skin care products |
CN106728898A (en) * | 2016-12-14 | 2017-05-31 | 广州青岚生物科技有限公司 | A kind of pharmaceutical composition for repairing skin barrier and preparation method thereof |
CN107412254A (en) * | 2017-06-17 | 2017-12-01 | 福建中医药大学 | The application of anoectochilus roxburghii polyose extract |
CN108685822A (en) * | 2018-08-13 | 2018-10-23 | 儒兰(福建)生物科技有限公司 | A kind of roxburgh anoectochilus terminal bud facial mask and roxburgh anoectochilus terminal bud extracting method |
CN113087816A (en) * | 2021-05-14 | 2021-07-09 | 南昌大学 | Preparation method of high-purity anoectochilus roxburghii polysaccharide |
CN114634535A (en) * | 2021-12-20 | 2022-06-17 | 嘉文丽(福建)化妆品有限公司 | Separation and purification method of anoectochilus formosanus glycoside and application of anoectochilus formosanus glycoside in soothing cosmetics |
CN115894731A (en) * | 2022-11-02 | 2023-04-04 | 福建中医药大学 | Anoectochilus roxburghii homogeneous polysaccharide and preparation method and application thereof |
-
2023
- 2023-08-31 CN CN202311122467.9A patent/CN116898780B/en active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101580554A (en) * | 2009-07-01 | 2009-11-18 | 韩金光 | Anoectochilus roxburghii polyose, applications thereof in pharmacy and preparation method of anoectochilus roxburghii polyose |
US20110082103A1 (en) * | 2009-10-05 | 2011-04-07 | China Medical University | Anoectochilus SPP. polysaccharide extracts for stimulating growth of advantageous bacteria, stimuating release of granulocyte colony-Stimulating factor, modulating T helper cell type I, and/or modulating T helper cell type II and uses of the same |
CN105079466A (en) * | 2014-05-16 | 2015-11-25 | 华中科技大学 | Jinxianlian effervescent tablet and preparation method thereof |
CN105079467A (en) * | 2014-05-16 | 2015-11-25 | 华中科技大学 | Method for extracting anoectochilus roxburghii and application of extracts of anoectochilus roxburghii |
CN106420521A (en) * | 2016-08-30 | 2017-02-22 | 广东丸美生物技术股份有限公司 | Anoectochilus roxburghiiv flavone extraction process and application thereof in skin care products |
CN106728898A (en) * | 2016-12-14 | 2017-05-31 | 广州青岚生物科技有限公司 | A kind of pharmaceutical composition for repairing skin barrier and preparation method thereof |
CN107412254A (en) * | 2017-06-17 | 2017-12-01 | 福建中医药大学 | The application of anoectochilus roxburghii polyose extract |
CN108685822A (en) * | 2018-08-13 | 2018-10-23 | 儒兰(福建)生物科技有限公司 | A kind of roxburgh anoectochilus terminal bud facial mask and roxburgh anoectochilus terminal bud extracting method |
CN113087816A (en) * | 2021-05-14 | 2021-07-09 | 南昌大学 | Preparation method of high-purity anoectochilus roxburghii polysaccharide |
CN114634535A (en) * | 2021-12-20 | 2022-06-17 | 嘉文丽(福建)化妆品有限公司 | Separation and purification method of anoectochilus formosanus glycoside and application of anoectochilus formosanus glycoside in soothing cosmetics |
CN115894731A (en) * | 2022-11-02 | 2023-04-04 | 福建中医药大学 | Anoectochilus roxburghii homogeneous polysaccharide and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
ZHAO, DAN-JIE: "Study on purification technology and antioxidant activity of polysaccharides from Anoectochilus roxburghii.", FOOD RESEARCH AND DEVELOPMENT, vol. 42, no. 20, 31 December 2021 (2021-12-31), pages 116 - 123 * |
黄琼: "金线莲多糖提取工艺优化及其体外抗氧化活性研究", 佛山科学技术学院学报(自然科学版), vol. 41, no. 3, 15 May 2023 (2023-05-15), pages 36 - 44 * |
Also Published As
Publication number | Publication date |
---|---|
CN116898780B (en) | 2024-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105998072B (en) | Pig brain extract, composition containing pig brain extract and application of pig brain extract | |
CN113181231B (en) | Composition with function of enhancing phagocytic activity of macrophages, application thereof and immune drug | |
CN112057546A (en) | A kind of propolis and Ganoderma lucidum spore powder composition and its preparation method and application | |
CN115919722A (en) | A kind of extract of Pandanus leaves and its preparation method and application | |
CN115844746B (en) | A kind of anti-inflammatory and repairing bodhi cream and preparation method thereof | |
CN116115541A (en) | Preparation method and application of soothing composition | |
CN106420459A (en) | Ginseng water live essence, preparation method thereof and facial mask containing same | |
CN101530455A (en) | Method for extracting antioxidant active substance in tasteless preserved soybean | |
CN105662895A (en) | Water-based wet tissue | |
JP2008255051A (en) | Ceramide synthesis promoter, skin barrier function-ameliorating agent, and agent for preventing and treating disease caused by ceramide synthesis trouble | |
CN106478830B (en) | A kind of preparation method of Flos Magnoliae Officinalis oligosaccharide and polysaccharide | |
CN111265443A (en) | Anti-aging essence skin care lotion containing codonopsis pilosula extract and preparation method of anti-aging essence skin care lotion | |
CN116602894B (en) | Skin care product containing python oil extract for delaying skin aging and removing wrinkles and preparation method thereof | |
CN116898780B (en) | Aromatic thread vine extract and its preparation process and application | |
CN118743664A (en) | Composition containing Hypericum perforatum flower/leaf/stem extract and preparation method thereof | |
CN112656734A (en) | Preparation method of dandelion extract, extract and application thereof | |
CN118285488A (en) | Composition for preventing and treating allergic rhinitis | |
CN116712358A (en) | Compound essential oil for skin and pharmaceutical composition containing same | |
WO2024227342A1 (en) | Use of aloe gel powder and composition of aloe gel powder and stachyose | |
CN118216591A (en) | Preparation method of black tea fermented liquid with composite whitening, stabilization, and antioxidant repair effects | |
US11938161B2 (en) | Use of ginseng alcohol extract in sleep-promoting health care products or foods | |
CN117503669A (en) | Whitening anti-wrinkle composition, preparation method and eye cream thereof | |
CN109223865A (en) | A kind of preparation method of Folium Mori alkaloid and the application for the Folium Mori alkaloid being prepared | |
CN115844773A (en) | Poria cocos extract and preparation method and application thereof | |
JP2009523785A (en) | Cosmetic composition containing Kaimatsuko extract as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |